2011 discharge: European Medicines Agency (EMA)

A discharge decision on the European Medicines Agency for 2011. Amendments alternately grant, approve or postpone discharge and closure of accounts, address ex post checks of experts' declarations of interest and management of conflicts of interest, the Court of Auditors' findings and Special Report 15/2012, staff selection and recruitment transparency, an IT services framework contract, remuneration of Member State services, and the Agency's role in protecting public and animal health.